News

A team of researchers led by Prof. Xiao Jun from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese ...
Siren Biotechnology is trying to raise $5 million via the type of crowdfunding round that’s rarely used by young drugmakers.
Latus Bio Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced upcoming oral and ...
Discover a study where researchers administered appetite-related hormones leptin and ghrelin directly into the brain.
Pesticides by themselves are a grave threat to global health. As is global warming. As is antibiotic resistance. Each of ...
In recent years, the development of sophisticated methodologies based on second- and third-generation sequencing has enabled the RNA community to explore ...
Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...
Fulcrum Therapeutics, Inc. ( NASDAQ: FULC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – ...
Ghost Drops, a prominent player in Canada's cannabis industry, has formally filed a legal claim against Health Canada. This action comes in response to mounting regulatory pressure regarding the brand ...